Lv1
50 积分 2023-08-23 加入
为高质量的临床试验而奋斗，为改变临床实践而奋斗，为医药进步和患者健康而奋斗~
Ocular toxicities of fibroblast growth factor receptor inhibitors: A review
2天前
已完结
The HPK1 Inhibitor A-745 Verifies the Potential of Modulating T Cell Kinase Signaling for Immunotherapy
9天前
已完结
Computational analysis of cancer genome sequencing data
13天前
已完结
FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRα-Positive, Platinum-Resistant Ovarian Cancer
3个月前
已完结
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
4个月前
已完结
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation
6个月前
已完结
皖公网安备34019202002308
